Oligomerization is not essential for growth suppression by p53 in p53-deficient osteosarcoma Saos-2 cells

Chikashi Ishioka, Hideki Shimodaira, Christoph Englert, Akira Shimada, Motonobu Osada, Li Qun Jia, Takao Suzuki, Makio Gamo, Ryunosuke Kanamaru

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)


The carboxy-terminal portion of the p53 protein contains the tetramerization domain, and the introduction of multiple missense mutations in this domain disrupts the formation of p53 tetramers, resulting in the production of dimeric or monomeric forms of p53. It has recently been shown that a single missense or nonsense mutation in this domain affects the functional properties of p53 both in yeast and in mammalian cells. In this study, we tested the oligomerization of p53 with mutations in the oligomerization domain, when expressed in a human osteosarcoma cell line, Saos-2, in vivo. We found that single point mutations, including two missense and two nonsense mutations, in the α-helix of the oligomerization domain disrupted the oligomerization of p53, but that p53 still retained its ability to inhibit colony formation of cells to some degree. These results suggest that oligomerization and the carboxy-terminal basic domain are not prerequisite for p53-dependent tumor suppression, and this may explain why few of the tumor-derived p53 mutations that have been examined so far are carboxy-terminal mutations.

Original languageEnglish
Pages (from-to)54-60
Number of pages7
JournalBiochemical and Biophysical Research Communications
Issue number1
Publication statusPublished - Mar 6 1997
Externally publishedYes

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'Oligomerization is not essential for growth suppression by p53 in p53-deficient osteosarcoma Saos-2 cells'. Together they form a unique fingerprint.

Cite this